{
    "organizations": [],
    "uuid": "f0895ec6c9614b343e4425e5db4dee3956199498",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-natco-pharma-says-cos-mekaguda-fac/brief-natco-pharma-says-cos-mekaguda-facility-undergoing-routine-u-s-fda-inspection-idUSFWN1Q405G",
    "ord_in_thread": 0,
    "title": "BRIEF-Natco Pharma Says Co's Mekaguda Facility Undergoing Routine U.S. FDA Inspection",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Natco Pharma Ltd:\n* NATCO PHARMA CLARIFIES ON NEWS ITEM ON US FDA INSPECTION AT CO‘S MEKAGUDA FACILITY IN TELANGANA\n* CO'S MANUFACTURING FACILITIES UNDERGO AUDITS FROM REGULATORY AUTHORITIES ON A REGULAR BASIS; INSPECTION IS NOT A MATERIAL EVENT‍​ Source text - bit.ly/2EozLQZ Further company coverage:\n ",
    "published": "2018-02-14T15:36:00.000+02:00",
    "crawled": "2018-02-15T20:40:53.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "natco",
        "pharma",
        "ltd",
        "natco",
        "pharma",
        "clarifies",
        "news",
        "item",
        "u",
        "fda",
        "inspection",
        "co",
        "mekaguda",
        "facility",
        "telangana",
        "co",
        "manufacturing",
        "facility",
        "undergo",
        "audit",
        "regulatory",
        "authority",
        "regular",
        "basis",
        "inspection",
        "material",
        "source",
        "text",
        "company",
        "coverage"
    ]
}